Ravi Rao
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Dr. Ravi M. Rao is Chief Medical Officer bij Swedish Orphan Biovitrum AB en lid van The Royal College of Physicians. Hij zit in de Raad van Bestuur van DBV Technologies SA. Dr. Rao was voorheen werkzaam als Chief Medical Officer bij Aeglea Biotherapeutics, Inc. en als Head-Global Medical Affairs bij GlaxoSmithKline Plc. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Cambridge en een doctoraatsdiploma aan het Imperial College London.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DBV TECHNOLOGIES | Directeur/Bestuurslid | 19-05-2021 |
| AUTOLUS THERAPEUTICS PLC | Directeur/Bestuurslid | 01-04-2024 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | 01-03-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01-11-2023 |
| SWEDISH ORPHAN BIOVITRUM AB | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
| SPYRE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 10-08-2020 |
| GSK PLC | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau